Tiantian Li1, Ellen M Greenblatt1,2,3, Michelle EyunJung Shin2, Theodore J Brown1,3, Crystal Chan4,5,6. 1. Lunenfeld-Tanenbaum Research Institute (LTRI), Sinai Health System, Toronto, Ontario, Canada. 2. Mount Sinai Fertility (MSF), Sinai Health System, Toronto, Ontario, Canada. 3. Department of Obstetrics and Gynaecology, University of Toronto, Toronto, Ontario, Canada. 4. Lunenfeld-Tanenbaum Research Institute (LTRI), Sinai Health System, Toronto, Ontario, Canada. crystal.chan@sinaihealth.ca. 5. Mount Sinai Fertility (MSF), Sinai Health System, Toronto, Ontario, Canada. crystal.chan@sinaihealth.ca. 6. Department of Obstetrics and Gynaecology, University of Toronto, Toronto, Ontario, Canada. crystal.chan@sinaihealth.ca.
Abstract
PURPOSE: Endometrial laminin subunit beta-3 (LAMB3) is a candidate gene whose expression distinguishes the endometrial window of receptivity (WOR) in human. This study aims to examine endometrial LAMB3 levels in patients with repeated implantation failure (RIF), in order to assess the ability of LAMB3 to predict pregnancy outcome. METHODS: Endometrial biopsies were taken during the WOR from 21 healthy volunteers in natural menstrual cycles and from 50 RIF patients in mock cycles prior to frozen embryo transfer (FET) cycles. Immunohistochemistry (IHC) staining of LAMB3 was performed, and the H-score was correlated with the pregnancy outcome in subsequent FETs. RESULTS: In healthy volunteers, endometrial LAMB3 was demonstrated to be highly expressed during the WOR with the staining exclusively in the cytoplasm of the epithelial cells. In a discovery set of RIF patients, the LAMB3 expression level was found to be significantly higher in those who conceived compared to those who did not in subsequent FETs. A receiving operator characteristic (ROC) analysis revealed an area under the curve (AUC) of 0.7818 (95% confidence interval 59.92-96.44%) with an H-score cutoff of 4.129 to differentiate cases with positive or negative pregnancy outcomes. This cutoff achieved an accuracy of 75% in pregnancy prediction in a following validation set of RIF patients, in which the pregnancy rate in subsequent FETs was three-fold higher when the mock cycle LAMB3 H-score was ≥ 4.129 compared to < 4.129. CONCLUSIONS: IHC measurement of endometrial LAMB3 expression could be a promising prognostic method to predict pregnancy outcome for RIF patients undergoing FETs.
PURPOSE: Endometrial laminin subunit beta-3 (LAMB3) is a candidate gene whose expression distinguishes the endometrial window of receptivity (WOR) in human. This study aims to examine endometrial LAMB3 levels in patients with repeated implantation failure (RIF), in order to assess the ability of LAMB3 to predict pregnancy outcome. METHODS: Endometrial biopsies were taken during the WOR from 21 healthy volunteers in natural menstrual cycles and from 50 RIF patients in mock cycles prior to frozen embryo transfer (FET) cycles. Immunohistochemistry (IHC) staining of LAMB3 was performed, and the H-score was correlated with the pregnancy outcome in subsequent FETs. RESULTS: In healthy volunteers, endometrial LAMB3 was demonstrated to be highly expressed during the WOR with the staining exclusively in the cytoplasm of the epithelial cells. In a discovery set of RIF patients, the LAMB3 expression level was found to be significantly higher in those who conceived compared to those who did not in subsequent FETs. A receiving operator characteristic (ROC) analysis revealed an area under the curve (AUC) of 0.7818 (95% confidence interval 59.92-96.44%) with an H-score cutoff of 4.129 to differentiate cases with positive or negative pregnancy outcomes. This cutoff achieved an accuracy of 75% in pregnancy prediction in a following validation set of RIF patients, in which the pregnancy rate in subsequent FETs was three-fold higher when the mock cycle LAMB3 H-score was ≥ 4.129 compared to < 4.129. CONCLUSIONS: IHC measurement of endometrial LAMB3 expression could be a promising prognostic method to predict pregnancy outcome for RIF patients undergoing FETs.
Authors: G Giannelli; C Sgarra; E Di Naro; C Lavopa; U Angelotti; M Tartagni; O Simone; P Trerotoli; S Antonaci; G Loverro Journal: Int J Gynecol Cancer Date: 2007 Jan-Feb Impact factor: 3.437
Authors: Anne Riesewijk; Julio Martín; Roselinde van Os; José Antonio Horcajadas; Jan Polman; Antonio Pellicer; Sietse Mosselman; Carlos Simón Journal: Mol Hum Reprod Date: 2003-05 Impact factor: 4.025
Authors: H Goulding; S Pinder; P Cannon; D Pearson; R Nicholson; D Snead; J Bell; C W Elston; J F Robertson; R W Blamey Journal: Hum Pathol Date: 1995-03 Impact factor: 3.466
Authors: D Haouzi; K Mahmoud; M Fourar; K Bendhaou; H Dechaud; J De Vos; T Rème; D Dewailly; S Hamamah Journal: Hum Reprod Date: 2008-10-03 Impact factor: 6.918
Authors: Maria Ruiz-Alonso; David Blesa; Patricia Díaz-Gimeno; Eva Gómez; Manuel Fernández-Sánchez; Francisco Carranza; Joan Carrera; Felip Vilella; Antonio Pellicer; Carlos Simón Journal: Fertil Steril Date: 2013-06-04 Impact factor: 7.329